Expression of transforming growth factors in hepatocellular carcinoma and its relations with clinicopathological parameters and prognosis

Hepatobiliary and Pancreatic Diseases International

Volumn 7, Issue 2, 2008, Pages 174-178

  Lu, Yun ^a   Wu, Li Qun ^a   Li, Chang Sheng ^a   Wang, Shou Guang ^a   Han, Bing ^a  

^a QINGDAO UNIVERSITY   (China)

Author keywords

Carcinoma; Hepatocellular; Immunohistochemistry; Transforming growth factor

Indexed keywords

SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; APOPTOSIS; ARTICLE; FEMALE; GROWTH INHIBITION; GROWTH REGULATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PORTAL VEIN OBSTRUCTION; PROGNOSIS; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TISSUE LEVEL; TUMOR VOLUME;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TRANSFORMING GROWTH FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 42149168576     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Abelev GI, Lazarevich NL. Control of differentiation in progression of epithelial tumors. Adv Cancer Res 2006;95: 61-113.
2. Cavin LG, Romieu-Mourez R, Panta GR, Sun J, Factor VM, Thorgeirsson SS, et al. Inhibition of CK2 activity by TGF-beta1 promotes IkappaB-alpha protein stabilization and apoptosis of immortalized hepatocytes. Hepatology 2003; 38:1540-1551.
3. Park DY, Sol MY, Suh KS, Shin EC, Kim CH. Expressions of transforming growth factor (TGF)-beta1 and TGF-beta type II receptor and their relationship with apoptosis during chemical hepatocarcinogenesis in rats. Hepatol Res 2003;27:205-213.
4. Guo H, Zhang HY, Wang SL, Ye L, Yang GH, Bu H. Smad4 and ERK2 stimulated by transforming growth factor beta1 in rhabdomyosarcoma. Chin Med J (Engl) 2007;120:515-521.
5. Clarke DC, Betterton MD, Liu X. Systems theory of Smad signalling. Syst Biol (Stevenage) 2006;153:412-424.
6. Saito H, Tsujitani S, Oka S, Kondo A, Ikeguchi M, Maeta M, et al. The expression of transforming, growth factor-beta1 is significantly correlated with the expression of vascular endothelial growth factor and poor prognosis of patients with advanced gastric carcinoma. Cancer 1999;86:1455-1462.
7. Kinugasa S, Abe S, Tachibana M, Hishikawa Y, Yoshimura H, Monden N, et al. Overexpression of transforming growth factor-beta1 in scirrhous carcinoma of the stomach correlates with decreased survival. Oncology 1998;55:582-587.
8. Kim YH, Lee HS, Lee HJ, Hur K, Kim WH, Bang YJ, et al. Prognostic significance of the expression of Smad4 and Smad7 in human gastric carcinomas. Ann Oncol 2004;15: 574-580.
9. Ueno T, Hashimoto O, Kimura R, Torimura T, Kawaguchi T, Nakamura T, et al. Relation of type II transforming growth factor-beta receptor to hepatic fibrosis and hepatocellular carcinoma. Int J Oncol 2001;18:49-55.
10. Zhang L, Yuan SZ. Expression of c-erbB-2 oncogene protein, epidermal growth factor receptor, and TGF-beta1 in human pancreatic ductal adenocarcinoma. Hepatobiliary Pancreat Dis Int 2002;1:620-623.
11. Han G, Lu SL, Li AG, He W, Corless CL, Kulesz-Martin M, et al. Distinct mechanisms of TGF-beta1-mediated epithelial-to-mesenchymal transition and metastasis during skin carcinogenesis. J Clin Invest 2005;115: 1714-1723.
12. Glick AB. TGFbeta1, back to the future: revisiting its role as a transforming growth factor. Cancer Biol Ther 2004;3: 276-283.
13. Andl CD, Fargnoli BB, Okawa T, Bowser M, Takaoka M, Nakagawa H, et al. Coordinated functions of E-cadherin and transforming growth factor beta receptor II in vitro and [i#in vivo#1i]. Cancer Res 2006;66:9878-9885.
14. Li X, Zhang YY, Wang Q, Fu SB. Association between endogenous gene expression and growth regulation induced by TGF-beta1 in human gastric cancer cells. World J Gastroenterol 2005;11:61-68.
15. Hrycek A, Kusmierz D, Dybala T, Swiatkowska L. Expression of messenger RNA for transforming growth factor-beta1 and for transforming growth factor-beta receptors in peripheral blood of systemic lupus erythematosus patients treated with low doses of quinagolide. Autoimmunity 2007;40:23-30.
16. Okano J, Matsumoto K, Nagahara T, Murawaki Y. Gefitinib and the modulation of the signaling pathways downstream of epidermal growth factor receptor in human liver cancer cells. J Gastroenterol 2006;41:166-176.
17. Shiou SR, Singh AB, Moorthy K, Datta PK, Washington MK, Beauchamp RD, et al. Smad4 regulates claudin-1 expression in a transforming growth factor-beta-independent manner in colon cancer cells. Cancer Res 2007;67:1571-1579.
18. Bardeesy N, Cheng KH, Berger JH, Chu GC, Pahler J, Olson P, et al. Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer. Genes Dev 2006;20:3130-3146.
19. Ijichi H, Chytil A, Gorska AE, Aakre ME, Fujitani Y, Fujitani S, et al. Aggressive pancreatic ductal adenocarcinoma in mice caused by pancreas-specific blockade of transforming growth factor-beta signaling in cooperation with active Kras expression. Genes Dev 2006; 20:3147-3160.
20. Furukawa T, Sunamura M, Horii A. Molecular mechanisms of pancreatic carcinogenesis. Cancer Sci 2006;97:1-7.
21. Losi L, Bouzourene H, Benhattar J. Loss of Smad4 expression predicts liver metastasis in human colorectal cancer. Oncol Rep 2007;17:1095-1099.
22. Seshimo I, Yamamoto H, Mishima H, Kurata A, Suzuki R, Ezumi K, et al. Expression and mutation of SMAD4 in poorly differentiated carcinoma and signet-ring cell carcinoma of the colorectum. J Exp Clin Cancer Res 2006; 25:433-442.
23. Kouvidou Ch, Latoufis C, Lianou E, Kouvatseas G, Kakouri E, Anagnostakis D, et al. Expression of Smad4 and TGF-beta2 in colorectal carcinoma. Anticancer Res 2006;26:2901-2907.
24. Beck SE, Jung BH, Fiorino A, Gomez J, Rosario ED, Cabrera BL, et al. Bone morphogenetic protein signaling and growth suppression in colon cancer. Am J Physiol Gastrointest Liver Physiol 2006;291:G135-145.
25. Chen W, Lam SS, Srinath H, Schiffer CA, Royer WE Jr, Lin K. Competition between Ski and CREB-binding protein for binding to Smad proteins in transforming growth factor-beta signaling. J Biol Chem 2007;282-11365-11376.
26. Hasegawa K, Yazumi S, Wada M, Sakurai T, Kida M, Yamauchi J, et al. Restoration of RUNX3 enhances transforming growth factor-beta-dependent p21 expression in a biliary tract cancer cell line. Cancer Sci 2007;98:838-843.
27. Davidson NO. Genetic testing in colorectal cancer: who, when, how and why. Keio J Med 2007;56:14-20.
28. + myeloid cells that promote invasion. Nat Genet 2007;39:467-475.
29. Wang LH, Kim SH, Lee JH, Choi YL, Kim YC, Park TS, et al. Inactivation of SMAD4 tumor suppressor gene during gastric carcinoma progression. Clin Cancer Res 2007;13: 102-110.
30. Izeradjene K, Combs C, Best M, Gopinathan A, Wagner A, Grady WM, et al. Kras(G12D) and Smad4/Dpc4 haploinsufficiency cooperate to induce mucinous cystic neoplasms and invasive adenocarcinoma of the pancreas. Cancer Cell 2007;11:229-243.
31. Takano S, Kanai F, Jazag A, Ijichi H, Yao J, Ogawa H, et al. Smad4 is essential for down-regulation of E-cadherin induced by TGF-beta in pancreatic cancer cell line PANC-1. J Biochem 2007;141:345-351.
32. Tong XD, Liu HX, Zhao HR, Xu SG, Li Y, Han LB, Zhang L. The role of Smad4 and MAPK proteins in signal transduction pathway in non-small cell lung cancer. Zhonghua Zhong Liu Za Zhi 2006;28:741-745.